Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP862261.RArxkNroQFkSJLitcWArI7a92_vxxEyBuCROeXZ-auYkQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP862261.RArxkNroQFkSJLitcWArI7a92_vxxEyBuCROeXZ-auYkQ130_assertion type Assertion NP862261.RArxkNroQFkSJLitcWArI7a92_vxxEyBuCROeXZ-auYkQ130_head.
- NP862261.RArxkNroQFkSJLitcWArI7a92_vxxEyBuCROeXZ-auYkQ130_assertion description "[An acid-ceramidase activity below 10% results in Farber disease, an early-onset disease starting with subcutaneous lipogranulomata, joint pain, and hoarseness of the voice, whereas a higher residual activity might be responsible for SMA-PME, a later-onset phenotype restricted to the CNS and starting with lower-motor-neuron disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862261.RArxkNroQFkSJLitcWArI7a92_vxxEyBuCROeXZ-auYkQ130_provenance.
- NP862261.RArxkNroQFkSJLitcWArI7a92_vxxEyBuCROeXZ-auYkQ130_assertion evidence source_evidence_literature NP862261.RArxkNroQFkSJLitcWArI7a92_vxxEyBuCROeXZ-auYkQ130_provenance.
- NP862261.RArxkNroQFkSJLitcWArI7a92_vxxEyBuCROeXZ-auYkQ130_assertion SIO_000772 22703880 NP862261.RArxkNroQFkSJLitcWArI7a92_vxxEyBuCROeXZ-auYkQ130_provenance.
- NP862261.RArxkNroQFkSJLitcWArI7a92_vxxEyBuCROeXZ-auYkQ130_assertion wasDerivedFrom befree-20140225 NP862261.RArxkNroQFkSJLitcWArI7a92_vxxEyBuCROeXZ-auYkQ130_provenance.
- NP862261.RArxkNroQFkSJLitcWArI7a92_vxxEyBuCROeXZ-auYkQ130_assertion wasGeneratedBy ECO_0000203 NP862261.RArxkNroQFkSJLitcWArI7a92_vxxEyBuCROeXZ-auYkQ130_provenance.